From fragmentation to integration: impact of the creation of the Psoriatic Disease Unit on comprehensive patient management
DOI:
https://doi.org/10.47196/a0kq1466Keywords:
psoriatic disease, interdisciplinaryAbstract
Introduction: psoriatic disease (PD) is an immune-mediated disease with a genetic predisposition that presents a chronic course associated with multifactorial triggers, leading to a significant impact on quality of life. It can affect the skin, mucosa, semimucosa, appendages, and joints. Due to its systemic nature and the frequent coexistence of comorbidities a comprehensive and individualized approach is essential.
Objectives: analyze the differences in healthcare, epidemiology, clinical aspects, and therapeutic management of adult patients with a confirmed diagnosis of PD before and after the establishment of the UEP.
Design: observational, analytical, retrospective and comparative temporal study.
Materials and methods: demographic, clinical, and therapeutic variables were collected from the medical records of patients with PD between 2022 and 2025.
Results: following the establishment of the PEU, a more efficient patient recruitment process was observed, with a significant reduction in the number of consultations and the time required for comprehensive evaluation (90 vs. 10 days, p<0.001). The prevalence of psoriatic arthritis (PsA) increased significantly (27% vs. 40%, p=0.018), doubling the data reported globally, and a greater number of comorbidities was detected (55% vs. 68%, p=0.008). Furthermore, a tangible impact on therapeutic strategy was recorded with an increase in the use of biological therapies (5% vs. 27%; p<0.001), achieving improvements in clinical outcomes and quality of life.
Conclusions: in our country, research on the interdisciplinary management of patients with EP is limited, which makes this strategy an innovative, reproducible proposal with high clinical impact.
References
I. Lavieri A, Acevedo A, Baccarini E, Crespo MA, et al. Consenso Nacional de Psoriasis: guía de tratamiento. Actualización 2024 [Internet]. Publicación de la Sociedad Argentina de Dermatología; 2024 [citado oct 2025]. Disponible en: https://sad.org.ar/wp-content/uploads/2024/08/CONSENSO-NACIONAL-PSORIASIS-2024.
II. Pérez-Chada LM, Elman S, Villa-Ruiz C, Armstrong AW, et al. Psoriatic arthritis. A comprehensive review for the dermatologist part I: Epidemiology, comorbidities, pathogenesis, and diagnosis. J Am Acad Dermatol. 2025;92:969-982.
III. Gottlieb A, Merola JF. Psoriatic arthritis for dermatologists. J Dermatol Treat. 2020;31:662-679.
IV. Mehta H, Narang T, Dogra S, Handa S, et al. Cardiovascular considerations and implications for treatment in psoriasis: an updated review. Vasc Health Risk Manag. 2024;20:215-229.
V. Mrowietz U, Lauffer F, Sondermann W, Gerdes S, et al. Psoriasis as a systemic disease. Dtsch Arzteblatt Int. 2024;121:467-472.
VI. Alinaghi F, Calov M, Kristensen LE, Gladman DD, et al. Prevalence of psoriatic arthritis in patients with psoriasis. A systematic review and meta-analysis of observational and clinical studies. J Am Acad Dermatol. 2019;80:251-265.
VII. Elman SA, Pérez-Chada LM, Armstrong A, Gottlieb AB, et al. Psoriatic arthritis: A comprehensive review for the dermatologist-Part II: Screening and management. J Am Acad Dermatol. 2025;92:985-998.
VIII. Giovannini I, Zabotti A, Cicciò C, Salgarello M, et al. Axial psoriatic disease: clinical and imaging assessment of an underdiagnosed condition. J Clin Med. 2021;10:2845.
IX. Attar JA, von Martial S, Troost K, Neumeister T, et al. Impact of a dermatological rehabilitation program on cardiovascular risks of psoriasis patients. Dtsch Dermatol Ges. 2025;23:161-171.
X. Ziob J, Behning C, Brossart P, Bieber T, et al. Specialized dermatological-rheumatological patient management improves diagnostic outcome and patient journey in psoriasis and psoriatic arthritis: a four-year analysis. BMC Rheumatol. 2021;5:45.
XI. Stolnicki DK, Coates LC, Gollins CE, Koppikar S, et al. Breakout session and report back: collaboration of rheumatologists and dermatologists for the care of patients with psoriatic disease. J Rheumatol. 2024;51:54-57.
XII. Luchetti MM, Benfaremo D, Campanati A, Molinelli E, et al. Clinical outcomes and feasibility of the multidisciplinary management of patients with psoriatic arthritis: two-year clinical experience of a dermo-rheumatologic clinic. Clin Rheumatol. 2018;37:2741-2749.
XIII. Luelmo J, Gratacós J, Moreno-Martínez-Losa M, Ribera M, et al. Experiencia de 4 años de funcionamiento de una unidad multidisciplinar de psoriasis y artritis psoriásica. Reumatol Clin. 2014;10:141-146.
XIV. Queiro R, Coto P, Rodríguez J, Notario J, et al. Modelos de atención multidisciplinar en pacientes con artritis psoriásica en España. Reumatol Clin. 2017;13:85-90.
XV. Foti R, Giuffrida G, Ramondetta A, Amato G, et al. Multidisciplinary rheuma-derma clinics: 5 years of experience at the San Marco Hospital in Catania. Dermatol Ther. 2022;12:2829-2837.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 on behalf of the authors. Reproduction rights: Argentine Dermatology
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
El/los autor/es tranfieren todos los derechos de autor del manuscrito arriba mencionado a Dermatología Argentina en el caso de que el trabajo sea publicado. El/los autor/es declaran que el artículo es original, que no infringe ningún derecho de propiedad intelectual u otros derechos de terceros, que no se encuentra bajo consideración de otra revista y que no ha sido previamente publicado.
Le solicitamos haga click aquí para imprimir, firmar y enviar por correo postal la transferencia de los derechos de autor
